echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Two sessions: these business representatives have spoken out, North China Pharmaceuticals, Kangyuan Pharmaceuticals, Eling Pharmaceuticals....

    Two sessions: these business representatives have spoken out, North China Pharmaceuticals, Kangyuan Pharmaceuticals, Eling Pharmaceuticals....

    • Last Update: 2020-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    REVIEW: two sessions focus on topics medicine, to see representatives of suggestionstoday (May 21), the opening of the Third Session of the CPPCC National Committee Thirteenth was held in Beijing, delegates, business owners have their own voice through different channels, from drugs to speed up innovation research and development, promote the different directions of medical information, intelligence upgrade, overall planning and development of Chinese herbal medicines and other suggestions put forwardSequoia Capital Global Managing Partner Neil Shen: soil optimization medical innovation, promote health information, intelligence upgradeCPPCC National Committee members, Sequoia Capital, global managing partner Neil Shen submitted new drug development and approval system reform, medical information and intelligence, a variety of infectious diseases prevention and control mechanism to build three proposals, optimizing soil pharmaceutical innovationdrug development and approval system reformpolicy reforms to promote new drug development, clinical trials, market full speed, drugs to stimulate innovation and vitality, increase the availability of innovative drugs, medical drugs effectively solve the needs of the people, is to enhance the important direction of the quality of life of the massesA review is to enhance the professional competence to provide investment protection, the introduction of expert resources to support drug trial personnel training; two-strokes rule optimization, rationally determine the Medicare price negotiations, including reasonable planning and Drug declinemedical information and intelligencepromote the profile of the health system construction at the national level, to build a data base of artificial intelligence for the medical and healthcare big data application development; deepen the reform of the review of medical devices, medical expedite the implementation of artificial intelligence equipment products on the market; some of the charges pilot projects, the development of medical AI product liability insurance, and promote clinical application and popularization; support to promote social forces to participate in health information technology upgrades, the introduction of professional medical organizations assisted AI approvalA variety of infectious diseases prevention and control mechanism constructionchange the "God of Wealth god of plague to go along with" the passive situation to a strategic repositioning of the Department of Infectious Diseases position in the health care system, to enhance the overall prevention and emergency response capabilities; enhance hospital infection technical support capabilities, improve hospital infection information, the right to evaluate the wisdom of intelligent systems in hospitals and other heavy construction services; comprehensive public health emergency supplies special reserve system, the establishment of epidemiology peacetime and wartime conversion mechanism rigorous and pragmatic able to fight a hard battle; improve the legal direct reporting system to ensure network efficiency(Securities Daily)chairman Xiao Wei Hong edge medicine: Construction of Chinese medicine to deal with major incidents Gonggongweisheng prevention and control system, speed up the establishment of innovative drug developmentChinese medicine to deal with major incidents Gonggongweisheng prevention and control system
    a need to accelerate the establishment and improvement of an integrated security system for the prevention and treatment of traditional Chinese medical treatment; Second, establish a rapid response mechanism to deal with Chinese medicine major infectious diseases; Third, the creation of innovative research collaboration platform for Chinese medicine antiviral medicine scientific research; IVthe establishment of backup power protection Chinese pharmaceutical enterprises to actively participate; Fifth, to build "cloud computing, networking and" big data platform system; six, improve policy support and support the development of Chinese medicine Huimin services; seven overall strengthening and popularization of Chinese medicine Media guideaccelerate infectious diseases series of traditional Chinese medicine research and developmenthis proposal for establishment of virus viral infections innovative drug research and development of traditional Chinese medicine major projects, speed up the viral infection series of traditional Chinese medicine research and development, well in advance for the possible future of all kinds of diseases Drug strategic reserveThe creation of innovative system found in traditional Chinese medicine, "the efficacy of the substance group found that disease - Syndrome - - target group" around(China Securities Journal)North China Pharmaceutical chairman Yang accounted for: to accelerate the implementation of the production and supply of drugs and implementation of procurement policiessmall breed small breed drug list system management, targeted drug manufacturers to take appropriate protection for species in the list measures; the second is to play a variety of small pharmaceutical production base advantage, foster the formation of a complete industrial chainTry to form a stable drug supply and procurement "sentinel production"; a small selection of pharmaceuticals production base members of the "sentinel" approach to exploration and feasibility studies(China Securities Journal) Wu Xiang-Jun, general manager ofYiling Pharmaceutical: overall planning and development of Chinese herbal medicines; Chinese medicine to strengthen the prevention and treatment of chronic diseases inpromote the development of high-quality Chinese herbal medicine plantingrecommends the reinforcement of traditional Chinese medicine overall planning development of timber industry, the establishment of 1 million mu planting goals, formulate scientific development plan, optimize the layout of Chinese herbal medicine production, increase policy support efforts to encourage county and township governments to expand the area under cultivation adapted to local conditionsThe establishment of Chinese herbal medicine purchasing and storage system, establish long-term joint effect of planting mechanism; promote the quality of medicines traceability, strengthen the process management, the establishment of production of norms, the source can be traced back, whereabouts can be verified, the responsibility of accountability of medicines quality tracing systemFirststrengthen Chinese medicine, Chinese medicine and vigorously carry out the "disease" concept of education in the prevention and treatment of chronic diseases, multi-angle multi-channel for disseminating the "disease" concept of traditional Chinese medicine; secondly, to promote early Chinese medicine interventional treatment of chronic diseases, screening is recommended evidence-based medicine through a number of studies have confirmed the efficacy of the treatment of chronic diseases exact modern medicine, essential drugs as first-line drugs and appropriate treatment of the disease at all levels of medical institutions, once the diagnosis of chronic determined, timely intervention by Traditional Chinese Medicine ; third is to enhance the coverage of medical services in the masses, promote the deepening medical schools Jiaoyugaige, adjust the structure of personnel training, strengthening discipline construction of Chinese medicine, improve personnel training system of both Chinese and Western medicine, as well as efforts to increase investment in the construction of Chinese medicine hospitalEditor China Securities Journal, Reuters, and other Securities Daily:: (Sina Finance)sources of information thirty-sevenDisclaimer: This article is syndicated content, views of the authors only and do not represent medicine Chi net position, welcome in the comments section exchanges supplement; For reprint, please be sure to indicate the source and author of the article Related Tags: a country, a two sessions, pharmaceutical reform 0 0
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.